Transgene SA TRGNF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1,158.84% | 741.42% | -91.41% | -96.01% | -98.78% |
| Total Other Revenue | -25.93% | -4.34% | 15.84% | 27.52% | 43.02% |
| Total Revenue | -20.49% | -0.55% | 17.53% | 16.92% | 17.46% |
| Cost of Revenue | -8.39% | -0.79% | 3.10% | 12.72% | 25.60% |
| Gross Profit | 5.25% | 0.85% | 0.18% | -11.66% | -27.91% |
| SG&A Expenses | 17.35% | 9.64% | -1.69% | -9.11% | -15.23% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 3,125.05% | 16,528.92% | 3,832.73% | 1,325.05% | 164.17% |
| Total Operating Expenses | -1.19% | 3.98% | 5.03% | 9.96% | 16.95% |
| Operating Income | -2.85% | -4.86% | -2.80% | -8.62% | -16.85% |
| Income Before Tax | 1.22% | -9.03% | -15.28% | -32.98% | -61.58% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 1.22% | -9.03% | -15.28% | -32.98% | -61.58% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.22% | -9.03% | -15.28% | -32.98% | -61.58% |
| EBIT | -2.85% | -4.86% | -2.80% | -8.62% | -16.85% |
| EBITDA | -2.64% | -4.62% | -2.55% | -8.86% | -17.73% |
| EPS Basic | 32.99% | 18.08% | 7.64% | -5.12% | -23.30% |
| Normalized Basic EPS | 32.98% | 18.11% | 7.66% | -5.14% | -23.54% |
| EPS Diluted | 33.28% | 17.76% | 6.60% | -6.80% | -25.91% |
| Normalized Diluted EPS | 32.98% | 18.11% | 7.66% | -5.14% | -23.54% |
| Average Basic Shares Outstanding | 62.68% | 44.51% | 23.88% | 27.15% | 30.91% |
| Average Diluted Shares Outstanding | 62.68% | 44.51% | 23.88% | 27.15% | 30.91% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |